DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
מצבים רפואיים
Haematological Malignancy · Colorectal Neoplasms · Urinary Bladder Neoplasm · Gallbladder Neoplasms · Salivary Gland Neoplasm · Lung Neoplasm · Pancreatic Neoplasm · Ovarian Neoplasms · Prostatic Neoplasm · Skin Neoplasm · Solid Tumour
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Belfast City Hospital, Belfast, United Kingdom
Contact: Principal Investigator (Vicky Coyle, Prof)University Hospital Birmingham, Birmingham, United Kingdom
Contact: Principal Investigator (Gary Middleton, Prof)Birmingham Children's Hospital, Birmingham, United Kingdom
Contact: Principal Investigator (Gerard Millen, Dr)Bristol Royal Hospital for Children, Bristol, United Kingdom
Contact: Principal Investigator (Antony Ng, Dr)Bristol Haematology and Oncology Centre, Bristol, United Kingdom
Contact: Principal Investigator (Antony Ng, Dr)Addenbrooke's Hospital, Cambridge, United Kingdom
Contact: Principal Investigator (Bristi Basu, Dr)Velindre Cancer Centre, Cardiff, United Kingdom
Contact: Principal Investigator (Robert Jones, Dr)Cardiff Children's Hospital, Cardiff, United Kingdom
Contact: Principal Investigator (Madeline Adams, Dr)Western General Hospital, Edinburgh, United Kingdom
Contact: Study coordinator (Stefan Symeonides, Dr)Contact: Principal Investigator (Stefan Symeonides, Dr)The Beatson Hospital, Glasgow, United Kingdom
Contact: Study coordinator (Patricia Roxburgh, Dr) · Patricia.Roxburgh@glasgow.ac.uk · 0141 301 7118Contact: Principal Investigator (Patricia Roxburgh, Dr)Royal Hospital for Children Glasgow, Glasgow, United Kingdom
Contact: Principal Investigator (Milind Ronghe, Dr)Leicester Royal Infirmary, Leicester, United Kingdom
Contact: Principal Investigator (Olubukola Ayodele, Dr)Alder Hey Hospital, Liverpool, United Kingdom
Contact: Principal Investigator (Lisa Howell, Dr)University College London Hospital, London, United Kingdom
Contact: Principal Investigator (Martin Forster, Prof)Guy's Hospital, London, United Kingdom
Contact: Principal Investigator (James Spicer, Dr)Great Ormond Street Hospital, London, United Kingdom
Contact: Principal Investigator (Darren Hargrave, Dr)Royal Manchester Children's Hospital, Manchester, United Kingdom
Contact: Principal Investigator (Guy Makin, Dr)The Christie Hospital, Manchester, United Kingdom
Contact: Principal Investigator (Matthew Krebs, Dr)Clatterbridge Cancer Centre, Metropolitan Borough of Wirral, United Kingdom
Contact: Study coordinator (Dan Palmer, Dr) · daniel.palmer@liverpool.ac.uk · 0151 706 4172 / 0151 706 4177Contact: Principal Investigator (Dan Palmer, Dr)Great North Children's Hospital, Newcastle, United Kingdom
Contact: Study coordinator (Alastair Greystoke, Dr) · Alastair.Greystoke@newcastle.ac.uk · 0191 2138476Contact: Principal Investigator (Alastair Greystoke, Dr)Freeman Hospital, Newcastle, United Kingdom
Contact: Principal Investigator (Alastair Greystoke, Dr)Churchill Hospital, Oxford, United Kingdom
Contact: Principal Investigator (Sarah Pratap, Dr)John Radcliffe Hospital, Oxford, United Kingdom
Contact: Principal Investigator (Sarah Pratap, Dr)Weston Park Hospital, Sheffield, United Kingdom
Contact: Principal Investigator (Sarah Danson, Dr)Sheffield's Children's Hospital, Sheffield, United Kingdom
Contact: Principal Investigator (Daniel Yeomanson, Dr)Southampton General Hospital, Southampton, United Kingdom
Contact: Principal Investigator (Juliet Gray, Prof)The Royal Marsden Hospital, Sutton, United Kingdom
Contact: Principal Investigator (Lynley Marshall, Dr)
מובילי המחקר
Matthew Krebs, Dr
Principal Investigator
The Christie Hospital